Internationally, scientists now have on file the genomes of more than 47,000 different samples of the virus that causes COVID-19 up from just one in January. Here's a transmission electron micrograph of SARS-CoV-2 virus particles (orange) isolated from a patient. National Institute of Allergy and Infectious Diseases/National Institutes of Health hide caption
Internationally, scientists now have on file the genomes of more than 47,000 different samples of the virus that causes COVID-19 up from just one in January. Here's a transmission electron micrograph of SARS-CoV-2 virus particles (orange) isolated from a patient.
Scientists are monitoring the virus that causes COVID-19 for genetic changes that could make a vaccine ineffective. But so far, they're not seeing any.
"There's nothing alarming about the way the coronavirus is mutating or the speed at which it's mutating," says Emma Hodcroft, a molecular epidemiologist at the University of Basel in Switzerland. "We don't think this will be a problem [for vaccines] in the short term."
"To date, there have been very few mutations observed," says Peter Thielen, a senior scientist at Johns Hopkins Applied Physics Laboratory. "And any mutations that we do see are likely not having an effect on the function of the virus itself."
That's good news for scientists working to produce an effective vaccine by the end of the year. And it reflects the enormous quantity of genetic information on SARS-CoV-2, the virus that causes COVID-19, that researchers have amassed since the virus appeared in China late last year.
In January, scientists were limited to just one whole genome sequence of the virus. "Today we have over 47,000 coronavirus genomes that have been submitted to international databases," Thielen says.
New genomes are added every day by teams of scientists from around the world. And each time a new one arrives, it gets a close examination, Thielen says.
"What we're looking for in the data is similarity between the virus that first emerged and the genome that had been deposited and any changes that have occurred in the virus," he says. And overall, the viruses circulating today look remarkably similar to the ones first identified in China.
There had been concern about mutations because SARS-CoV-2 is a type of virus capable of quickly changing its genes. But unlike many similar viruses, the coronavirus uses a proofreading system to catch any errors in the genetic code when it begins generating copies of itself.
"The targets for vaccine design today remain the same as we would have designed them in January."
Peter Thielen, Johns Hopkins Applied Physics Laboratory
"So if there's a change, it will actually make a correction at a specific location," Thielen says.
Vaccine developers have been especially concerned about genetic locations that affect something called a spike protein. It's a structure on the surface of the coronavirus that allows it to invade cells.
Spike proteins also give the virus its distinctive appearance and account for its name. Scientists who first viewed a coronavirus through an electron microscope were reminded of the solar corona.
The candidates for a coronavirus vaccine now under development are all designed to teach the immune system to recognize these spike proteins. So far, Thielen says, that's looking like a good strategy.
"The targets for vaccine design today remain the same as we would have designed them in January," he says.
Some other well-known viruses have proved less amenable to the strategy of using the same vaccine from year to year. Influenza, for example, is constantly altering its surface proteins in ways that require annual vaccine updates for each strain that's making the rounds that year.
"Flu just really loves to change these parts," Hodcroft says. "And that's why we can end up with such different flus from season to season."
Measles represents a virus at the other extreme its genome has stayed fairly consistent over the years, at least in the ways that trigger immunity in people after infection. That means children today still get a measles vaccine that was developed in the 1960s, and it provides immunity for a lifetime.
Hodcroft says she thinks SARS-CoV-2 is likely to fall somewhere between the flu and measles when it comes to making a vaccine.
"I think in the short term we'll find something," she says. "The big question is whether this is something we'll be able to vaccinate once and then you never have to get it again, or will it be something you'll have to get every couple of years to keep your immunity up to date."
Scientists are uncertain because the coronavirus is still so new, Hodcroft says.
"We haven't really seen the full diversity of how the virus can mutate," she says. "It gathers mutations over time. We can't speed up time, so we just have to wait and see."
At the moment, though, vaccine developers have more pressing concerns than mutations. First, they'll have to demonstrate that they can produce vaccines that are both safe and effective. Then they'll have to make huge quantities.
"It's not a small feat to manufacture a vaccine for billions of people and then to get it to all of those people," Hodcroft says.
That will take months, she says, in addition to the months required to develop a vaccine in the first place.
See original here:
Coronavirus's Genetics Not Changing Much, And That Bodes Well For A Vaccine : Shots - Health News - NPR
- Researchers Uncover One Million New Components of the Human Genome - India Education Diary - February 18th, 2024
- Ancient retroviruses played a key role in the evolution of vertebrate brains - EurekAlert - February 18th, 2024
- New Scientific Reports publication reveals major difference in genomes of American and Chinese chestnut - EurekAlert - January 17th, 2024
- The Crucial Role of Molecular Biology in Cancer Therapy: A Comprehensive Review - Cureus - January 17th, 2024
- Cells of the future: A key to reprogramming cell identities - EurekAlert - December 22nd, 2023
- Mainz Biomed Expands Corporate Health Program for ColoAlert with the Addition of Three New Companies in Germany - Marketscreener.com - April 7th, 2023
- Molecular Genetics and Metabolism | Journal - ScienceDirect - December 11th, 2022
- People don't mate randomly but the flawed assumption that they do is an essential part of many studies linking genes to diseases and traits - The... - November 25th, 2022
- Molecular and Cell Biology and Genetics - Master of Science / PhD ... - October 7th, 2022
- NIPD Genetics: Leading Genetic Testing Company - October 7th, 2022
- Skeletal Biology and Regeneration Students Recognized For Research Excellence - UConn Today - University of Connecticut - October 7th, 2022
- Mary Munson elected fellow of the American Society for Cell Biology - UMass Medical School - October 7th, 2022
- Every Body's Talking at Them: an Interview with Jon Lieff - CounterPunch - October 7th, 2022
- TriBeta invites students to explore opportunities to work with faculty at research fair on Oct. 11 - Ohio University - October 7th, 2022
- Genetics: the Vatican Does Not Intend to Be Behind the Times - FSSPX.News - October 7th, 2022
- Yield10 Bioscience Appoints Willie Loh, Ph.D., to the Board of Directors - citybiz - October 7th, 2022
- Molecular pathways of major depressive disorder converge on the synapse | Molecular Psychiatry - Nature.com - October 7th, 2022
- Sigyn Therapeutics Strengthens Board of Directors With the Appointments of Richa Nand, Jim Dorst and Christopher Wetzel - Yahoo Finance - October 7th, 2022
- UTHSC Researcher Co-Leads Study of Genes that Modulate Aging, Lifespan - UTHSC News - UTHSC News - October 7th, 2022
- GATC Health Investor Conference to Feature First Public Demonstration of Its AI Platform's Drug Discovery Capabilities - PR Newswire - October 7th, 2022
- Three Professors Conferred Tenure and Eleven Promoted - Wesleyan Argus - October 7th, 2022
- Who will get the call from Stockholm? It's time for STAT's 2022 Nobel Prize predictions - STAT - October 7th, 2022
- Dalhousie to present exhibition celebrating Gerhard Herzberg and his legacy - Dal News - October 7th, 2022
- Why Some People Should Rethink Their Morning Cup Of Coffee - Health Digest - October 7th, 2022
- Cell and Gene Therapy: Rewriting the Future of Medicine - Technology Networks - October 7th, 2022
- UofL researchers lead the call to increase genetic diversity in immunogenomics - uoflnews.com - July 6th, 2021
- In Brief This Week: Foundation Medicine, Myriad Genetics, Genetron Health, and More - GenomeWeb - July 6th, 2021
- More filling? Tastes great? How flies, and maybe people, choose their food - Yale News - July 6th, 2021
- Genetic mapping of subsets of patients with fragile X syndro | TACG - Dove Medical Press - July 6th, 2021
- What is The Babydust Method? Danielle Lloyd swears method helped her conceive girl - The Mirror - July 6th, 2021
- Datar Cancer Genetics joins hands with US based Iylon Precision Oncology to offer personalized Precision Oncology cancer treatment solutions - PR Web - July 6th, 2021
- Mapping a pathway to competitive production - hortidaily.com - hortidaily.com - July 6th, 2021
- Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma. - Physician's Weekly - July 6th, 2021
- Global Genomics Market | Rising Incidence of Chronic and Genetic Diseases are Key Factors to Grow Market During 2021-2029 | 23andMe, Agilent... - July 6th, 2021
- The Babydust Method Danielle Lloyd used to conceive a girl after four sons and how it works - RSVP Live - July 6th, 2021
- In the beginning science and faith - The Irish Times - June 24th, 2021
- Ancient Maya Maintained Native Tropical Forest Plants around Their Water Reservoirs | Archaeology - Sci-News.com - June 24th, 2021
- Local foundation awards $1.25 million to MIND Institute to study rare genetic condition - UC Davis Health - June 24th, 2021
- Xlife Sciences AG: Collaboration with the University of Marburg - Yahoo Finance - June 24th, 2021
- Genetics diagnostics in India is on the verge of transformation: Neeraj Gupta, Founder and CEO of Genes2me - The Financial Express - June 24th, 2021
- Precision Medicine: Improving Health With Personalized Solutions - BioSpace - June 24th, 2021
- Half of Portland areas 22 top National Merit winners hail from just 2 schools - OregonLive - June 24th, 2021
- Investing in stem cells, the building blocks of the body - MoneyWeek - June 24th, 2021
- New study finds low levels of a sugar metabolite associates with disability and neurodegeneration in multiple sclerosis - Newswise - May 14th, 2021
- Cernadas-Martn Is a Champion for Marine and Human Diversity | | SBU News - Stony Brook News - May 14th, 2021
- Four Penn Faculty: Election to the National Academy of Sciences - UPENN Almanac - May 14th, 2021
- Is there a difference between a gene-edited organism and a 'GMO'? The question has important implications for regulation - Genetic Literacy Project - May 14th, 2021
- 5 Students Inducted Into American Society for Biochemistry and Molecular Biology Honor Society - Wesleyan Connection - May 14th, 2021
- The Science of Aliens, Part 2: What Kind of Genetic Code Would Extraterrestrials Have? - Air & Space Magazine - May 14th, 2021
- UT Austin Faculty Member Receives 2021 Piper Professor Award - Office of the Executive Vice President and Provost - UT News | The University of Texas... - May 14th, 2021
- Distinguished University of Birmingham plant scientist elected to the Royal Society - University of Birmingham - May 14th, 2021
- Double Hoo Research: Undergrads and Grads Team Up to Create Knowledge - University of Virginia - May 14th, 2021
- Global Genetic Testing Market Top Countries Analysis and Manufacturers With Impact of COVID-19 | 2021-2028 Detail Analysis focusing on Application,... - May 14th, 2021
- Morag Park named to the Order of Quebec - McGill Reporter - McGill Reporter - May 14th, 2021
- Third Rock Ventures Launches Flare Therapeutics With $82 Million Series A - BioSpace - May 14th, 2021
- The Royal Society announces election of new Fellows 2021 - Cambridge Network - May 14th, 2021
- Researchers Decode the "Language" of Immune Cells - Technology Networks - May 14th, 2021
- RepliCel Launches the Next Stage of a Research Project with the University of British Columbia to Build World-Class Hair Follicle Cell Data Map -... - May 14th, 2021
- Mice Sperm Sabotage Other Swimmers With Poison | Smart News - Smithsonian Magazine - February 14th, 2021
- Study Identifies Never-Before-Seen Dual Function in Enzyme Critical for Cancer Growth - Newswise - February 14th, 2021
- Devious sperm 'poison' their rivals, forcing them to swim in circles until they die - Livescience.com - February 14th, 2021
- More needs to be done to find and fight COVID-19 variants, says Colorado researcher - FOX 31 Denver - February 14th, 2021
- Selfish sperm genes 'poison' the competition for the win - Big Think - February 14th, 2021
- Some sperm cells swim faster and even poison their competition to climb to the top - ZME Science - February 14th, 2021
- We are scientists: U of T researchers reach out to girls and women around the world - News@UofT - February 14th, 2021
- Mutations in frogs point to autism genes' shared role in neurogenesis - Spectrum - February 14th, 2021
- Global Genetic Testing Market Insights, Size Estimation, Research Insights, COVID-19 Impact and Future Trends By 2028 KSU | The Sentinel Newspaper -... - February 14th, 2021
- Acer Therapeutics Announces Topline Results from its Bioequivalence Trial of ACER-001 Compared to BUPHENYL Under Fed Conditions - GlobeNewswire - February 14th, 2021
- GeneSight Psychotropic Test's Combinatorial Approach Proves Better than Single-Gene Testing at Predicting Patient Outcomes and Medication Blood Levels... - February 14th, 2021
- Gu Ailing Eileen: I've learned to win for myself, not other people - Olympic Channel - February 14th, 2021
- Model organisms are more than just monkeys and mice - DW (English) - February 7th, 2021
- Dascena Strengthens Executive Leadership Team with Key Appointments and Promotion - Business Wire - February 7th, 2021
- PLUs Lathiena Nervo discusses her work and being named one of the 1,000 inspiring Black scientists in America - Pacific Lutheran University - February 7th, 2021
- Bioinformatics Services Market | Know the Latest Innovations and Future Market Scope - BioSpace - February 7th, 2021
- Plants May Be Able To Control the Genetics of Their Microbial Symbionts - Technology Networks - February 7th, 2021
- Risk Factor For Bacterial And Viral Co-Infection Uncovered - Forbes - February 7th, 2021
- The mistrusted medical miracle: Vaccines have revolutionized health, but some still question their safety - Charleston Gazette-Mail - February 7th, 2021
- US rushes to catch up in the race to detect mutant viruses - WWLTV.com - February 7th, 2021
- Of a Feather: When cousins are two of a kind - eagletimes.com - February 7th, 2021
- Beyond DNA: The rest of the story - Science Magazine - February 7th, 2021